Barry Logan
PhD, F-ABFT, Sr. Vice President of Forensic Science Initiatives, Chief Scientist
NMS Labs
Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one 100 publications and 400 presentations in forensic toxicology and analytical chemistry,
including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death. His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban Philadelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University. In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).
Fentanyl Analogues Causing the Convergence of Science and Law: The Truth of the Evolving Fentanyl Analogue Epidemic
Fentanyl Analogues: Investigation and Prosecution in the New World
PhD, F-ABFT, Sr. Vice President of Forensic Science Initiatives, Chief Scientist
NMS Labs
Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one 100 publications and 400 presentations in forensic toxicology and analytical chemistry,
including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death. His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban Philadelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University. In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).
Fentanyl Analogues Causing the Convergence of Science and Law: The Truth of the Evolving Fentanyl Analogue Epidemic
Fentanyl Analogues: Investigation and Prosecution in the New World
Jan Losby
PhD, MSW, Team Lead, Prescription Drug Overdose Health Systems Team
Centers for Disease Control and Prevention
Jan Losby, PhD, MSW, is the Team Lead for the Prescription Drug Overdose Health Systems Team in Center for Disease Control and Prevention (CDC) Division of Unintentional Injury Prevention. This team is responsible for implementing the CDC prescribing guideline in clinical settings, conducting applied health systems research, and providing scientific support to state public health departments. Prior to joining CDC, Dr. Losby managed the evaluation arm of a nonprofit evaluation organization where she designed and conducted evaluations of social service and public health programs in welfare reform, asset development, refugee services, mental health, substance abuse and employment.
CDC Guideline: Implementing Clinical and Practice-Level Strategies
Using EHR-Based Clinical Decision Supports to Affect Opioid Prescribing Behavior
PhD, MSW, Team Lead, Prescription Drug Overdose Health Systems Team
Centers for Disease Control and Prevention
Jan Losby, PhD, MSW, is the Team Lead for the Prescription Drug Overdose Health Systems Team in Center for Disease Control and Prevention (CDC) Division of Unintentional Injury Prevention. This team is responsible for implementing the CDC prescribing guideline in clinical settings, conducting applied health systems research, and providing scientific support to state public health departments. Prior to joining CDC, Dr. Losby managed the evaluation arm of a nonprofit evaluation organization where she designed and conducted evaluations of social service and public health programs in welfare reform, asset development, refugee services, mental health, substance abuse and employment.
CDC Guideline: Implementing Clinical and Practice-Level Strategies
Using EHR-Based Clinical Decision Supports to Affect Opioid Prescribing Behavior
Kathryn Lowerre
PhD, MPH, Evaluator
New Mexico Department of Health
Dr. Kathryn Lowerre joined the New Mexico Department of Health (NMDOH) in 2014 as the Bureau Evaluator for Environmental Health Epidemiology, working with multiple Centers for Disease Control and Prevention-funded programs engaging stakeholders and presenting evaluation findings to a range of audiences. In April 2016 she moved to NMDOH’s Prescription Drug Overdose Prevention Program. Previous positions include college and university teaching appointments, as well as work at county and regional health departments on health impact assessments and population health indicators and in drug regulatory affairs as a consultant. Her first health-related position, in clinical trials coordination, was at the Duke AIDS Research and Treatment Center, where she volunteered and worked part-time while completing her doctorate.
Implementation and Evaluation of New Mexico’s PDMP Mandate Legislation in Context
PhD, MPH, Evaluator
New Mexico Department of Health
Dr. Kathryn Lowerre joined the New Mexico Department of Health (NMDOH) in 2014 as the Bureau Evaluator for Environmental Health Epidemiology, working with multiple Centers for Disease Control and Prevention-funded programs engaging stakeholders and presenting evaluation findings to a range of audiences. In April 2016 she moved to NMDOH’s Prescription Drug Overdose Prevention Program. Previous positions include college and university teaching appointments, as well as work at county and regional health departments on health impact assessments and population health indicators and in drug regulatory affairs as a consultant. Her first health-related position, in clinical trials coordination, was at the Duke AIDS Research and Treatment Center, where she volunteered and worked part-time while completing her doctorate.
Implementation and Evaluation of New Mexico’s PDMP Mandate Legislation in Context
Conrae Lucas-Adkins
PsyD, MA, Assistant Professor, Department of School Psychology
Marshall University
Dr. Conrae Lucas-Adkins is an Assistant Professor of school psychology in the College of Education and Professional Development at Marshall University. She earned her undergraduate, graduate and specialist degrees from Marshall University. Lucas worked as an outpatient and school-based therapist for a local community mental health agency for four years and as a full-time school psychologist in West Virginia for 14 years, prior to joining the faculty at Marshall University. Lucas is licensed as a school psychologist by the West Virginia Board of Examiners of Psychologists and continues to practice school psychology on a contractual basis in West Virginia public schools. Her current research interests include examining the long-term effects of neonatal abstinence syndrome on the cognitive, behavioral and emotional development of children and building supports within the schools to support this population.
Using What We Know: Helping Teachers, Families and Communities Respond Systematically to Children Affected by Familial SUD
PsyD, MA, Assistant Professor, Department of School Psychology
Marshall University
Dr. Conrae Lucas-Adkins is an Assistant Professor of school psychology in the College of Education and Professional Development at Marshall University. She earned her undergraduate, graduate and specialist degrees from Marshall University. Lucas worked as an outpatient and school-based therapist for a local community mental health agency for four years and as a full-time school psychologist in West Virginia for 14 years, prior to joining the faculty at Marshall University. Lucas is licensed as a school psychologist by the West Virginia Board of Examiners of Psychologists and continues to practice school psychology on a contractual basis in West Virginia public schools. Her current research interests include examining the long-term effects of neonatal abstinence syndrome on the cognitive, behavioral and emotional development of children and building supports within the schools to support this population.
Using What We Know: Helping Teachers, Families and Communities Respond Systematically to Children Affected by Familial SUD
William Lynch
RPh, BPharm, Clinical Staff Pharmacist
Jefferson Health System, atTAcK addiction and Camden County (New Jersey) Addiction Awareness Task Force
William Lynch, RPh, BPharm, received his pharmacy degree from Rutgers University and is a practicing Clinical Staff Pharmacist with Kennedy University Hospital (KUH), the major core teaching affiliate with the Rowan School of Osteopathic Medicine (RSOM), where he serves as Adjunct Clinical Faculty. His pharmacy background includes more than 30 years of clinical practice at KUH/RSOM and as a clinical preceptor for Rutgers University, Ernest Mario School of Pharmacy, along with being a healthcare professional partner of the Delaware Prevention Coalition and State of Delaware Substance Abuse Epidemiological Working Group. Lynch is a member of the Camden County New Jersey Addiction Awareness Task Force (CCAATF), where he co-chairs the Education and Prevention Committee, and he is an Advisory Board Member with atTAcK addiction. Lynch is a certified New Jersey Department of Law and Public Safety Division of Criminal Justice Police Training Commission Instructor. He is the overnight clinical staff pharmacist at KUH, which specializes in behavioral medicine providing pediatric, adolescent, and adult psychological care, 24/7 crisis intervention, and drug and alcohol detoxification and treatment services.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
RPh, BPharm, Clinical Staff Pharmacist
Jefferson Health System, atTAcK addiction and Camden County (New Jersey) Addiction Awareness Task Force
William Lynch, RPh, BPharm, received his pharmacy degree from Rutgers University and is a practicing Clinical Staff Pharmacist with Kennedy University Hospital (KUH), the major core teaching affiliate with the Rowan School of Osteopathic Medicine (RSOM), where he serves as Adjunct Clinical Faculty. His pharmacy background includes more than 30 years of clinical practice at KUH/RSOM and as a clinical preceptor for Rutgers University, Ernest Mario School of Pharmacy, along with being a healthcare professional partner of the Delaware Prevention Coalition and State of Delaware Substance Abuse Epidemiological Working Group. Lynch is a member of the Camden County New Jersey Addiction Awareness Task Force (CCAATF), where he co-chairs the Education and Prevention Committee, and he is an Advisory Board Member with atTAcK addiction. Lynch is a certified New Jersey Department of Law and Public Safety Division of Criminal Justice Police Training Commission Instructor. He is the overnight clinical staff pharmacist at KUH, which specializes in behavioral medicine providing pediatric, adolescent, and adult psychological care, 24/7 crisis intervention, and drug and alcohol detoxification and treatment services.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
Kent MacLennan
MA, Executive Director
Rise Above Colorado
Kent MacLennan is proud to lead the organization into its next phase as the Executive Director of Rise Above Colorado. As the founding Executive Director for the Colorado Meth Project, he has overseen local public service messaging, public policy, fundraising and community outreach efforts to reduce first-time meth use. In May 2009, Colorado was the sixth of eight states to adopt the Meth Project, which as been nationally recognized for its extensive research, integrated media campaign and proven results. MacLennan has more than 20 years of progressive leadership experience in the nonprofit sector. He spent nearly 15 years in the development field for youth-serving and educational organizations, including Young Amercias Center for Financial Education, the University of Denver and Up With People. He has direct experience working with the teenage demographic targeted by the Colorado Meth Project, having taught social studies for two years at Pomona High School in Arvada. MacLennan holds a bachelor's degree in foreign service from Georgetown University and a master's degree in education from the University of Denver.
Colorado AmeriCorps Community Opioid Response Program
MA, Executive Director
Rise Above Colorado
Kent MacLennan is proud to lead the organization into its next phase as the Executive Director of Rise Above Colorado. As the founding Executive Director for the Colorado Meth Project, he has overseen local public service messaging, public policy, fundraising and community outreach efforts to reduce first-time meth use. In May 2009, Colorado was the sixth of eight states to adopt the Meth Project, which as been nationally recognized for its extensive research, integrated media campaign and proven results. MacLennan has more than 20 years of progressive leadership experience in the nonprofit sector. He spent nearly 15 years in the development field for youth-serving and educational organizations, including Young Amercias Center for Financial Education, the University of Denver and Up With People. He has direct experience working with the teenage demographic targeted by the Colorado Meth Project, having taught social studies for two years at Pomona High School in Arvada. MacLennan holds a bachelor's degree in foreign service from Georgetown University and a master's degree in education from the University of Denver.
Colorado AmeriCorps Community Opioid Response Program
Cydney Maddox
Member, Teen Advisory Council
Georgia Prevention Project
Cydney Maddox is a senior at Lassiter High School, and she is President of the school's Teen Advisory Council (TAC) chapter. In her own words: "In TAC, we implement community level change strategies to combat the growing rate of prescription drug abuse and addiction in our community. Ever since I first got involved in TAC during my sophomore year, I have been able to make a tremendous difference in the lives of my neighbors and peers. My passion for prevention stems from Kaitlin Merchan’s and Connor Nettels’s belief that individual students can be leaders and make a difference. Drug prevention is so important to me personally, that is the subject of my Gold Award. Outside of school, I like to serve my community in Girl Scouts and learn about languages and cultures. I hope to attend Hampton University this fall, majoring in international studies and minoring in Spanish."
Prevention for Youth, by Youth
Member, Teen Advisory Council
Georgia Prevention Project
Cydney Maddox is a senior at Lassiter High School, and she is President of the school's Teen Advisory Council (TAC) chapter. In her own words: "In TAC, we implement community level change strategies to combat the growing rate of prescription drug abuse and addiction in our community. Ever since I first got involved in TAC during my sophomore year, I have been able to make a tremendous difference in the lives of my neighbors and peers. My passion for prevention stems from Kaitlin Merchan’s and Connor Nettels’s belief that individual students can be leaders and make a difference. Drug prevention is so important to me personally, that is the subject of my Gold Award. Outside of school, I like to serve my community in Girl Scouts and learn about languages and cultures. I hope to attend Hampton University this fall, majoring in international studies and minoring in Spanish."
Prevention for Youth, by Youth
Andrea Magermans
Prescription Drug Monitoring Program Managing Director
Wisconsin Department of Safety and Professional Services
Andrea Magermans is currently the Managing Director of the Wisconsin Prescription Drug Monitoring Program (WI PDMP) at the Wisconsin Department of Safety and Professional Services. She joined the department in December 2012 as a Program and Policy Analyst to oversee the training and outreach efforts for the launch of the WI PDMP in 2013. Since then, she collaborated as Deputy Managing Director on all aspects of the operations and enhancement of the WI PDMP, including the development of the Wisconsin Enhanced Prescription Drug Monitoring Program in 2017. She became Managing Director in September 2017.
PDMP Innovations: Washington’s Prescriber Feedback and Wisconsin’s Data Analytics
Prescription Drug Monitoring Program Managing Director
Wisconsin Department of Safety and Professional Services
Andrea Magermans is currently the Managing Director of the Wisconsin Prescription Drug Monitoring Program (WI PDMP) at the Wisconsin Department of Safety and Professional Services. She joined the department in December 2012 as a Program and Policy Analyst to oversee the training and outreach efforts for the launch of the WI PDMP in 2013. Since then, she collaborated as Deputy Managing Director on all aspects of the operations and enhancement of the WI PDMP, including the development of the Wisconsin Enhanced Prescription Drug Monitoring Program in 2017. She became Managing Director in September 2017.
PDMP Innovations: Washington’s Prescriber Feedback and Wisconsin’s Data Analytics
Ajay Manhapra
MD, Physician, Research Scientist, Lecturer
Hampton VA Medical Center, New England Mental Illness Research, Education and Clinical Center, Yale School of Medicine
Dr. Ajay Manhapra was a practicing hospitalist managing complexly ill patients for over a decade before he made a career transition to addiction medicine and research. After a two-year VA-funded fellowship at Yale University, he started a primary care based clinic for patients with severe chronic disabling pain who have failed several treatment interventions. The clinic follows a whole-person approach to help these patients recover their functional life. In the clinic, they focus on multimorbidity as the main target of pain treatment, combining medical and psychiatric care, treatment of dependence and addiction, and polypharmacy management with behavioral treatment of pain. He also continues his research related to addiction and comorbidities through his affiliations at Yale School of Medicine and VA New England MIRECC.
VA Data about Rx Opioids and Overdose and Suicide: Clinical Implications
MD, Physician, Research Scientist, Lecturer
Hampton VA Medical Center, New England Mental Illness Research, Education and Clinical Center, Yale School of Medicine
Dr. Ajay Manhapra was a practicing hospitalist managing complexly ill patients for over a decade before he made a career transition to addiction medicine and research. After a two-year VA-funded fellowship at Yale University, he started a primary care based clinic for patients with severe chronic disabling pain who have failed several treatment interventions. The clinic follows a whole-person approach to help these patients recover their functional life. In the clinic, they focus on multimorbidity as the main target of pain treatment, combining medical and psychiatric care, treatment of dependence and addiction, and polypharmacy management with behavioral treatment of pain. He also continues his research related to addiction and comorbidities through his affiliations at Yale School of Medicine and VA New England MIRECC.
VA Data about Rx Opioids and Overdose and Suicide: Clinical Implications
Denise Mariano
Consultant and Parent Coach
Partnership for Drug-Free Kids
Denise Mariano’s work and advocacy efforts spread far and wide, however, her focus remains on advocating for and supporting families impacted by substance use disorder. She has been a strong voice for families at the national and state levels since, 2011. Mariano was selected and honored at the White House as an Advocate for Action, where she was recognized as one of the leaders across the country making a difference. She also was selected as a National Council on Alcoholism and Drug Dependence Advocacy Leader for her efforts in New Jersey. Mariano is a Peer Parent Coach at the Partnership for Drug-Free Kids and works within the Parent Support Network, where she helps develop and promote programs to support families struggling with substance use disorders and to encourage healthier behaviors and improve family cohesion. This work is based upon Community Reinforcement and Family Training, or CRAFT, and Motivational Interviewing, evidence-based models. She also serves as an Ambassador for the Partnership. Mariano is a member of her County Task Force on Opiates, a member of Faces and Voices, D.C. Program Outreach Committee and a member of New Jersey’s Experience, Hope and Strength Recovery High School Fund Raising Committee.
Empowering Families: How to Address a Loved One’s Opioid Use and Become a Family Advocate
Consultant and Parent Coach
Partnership for Drug-Free Kids
Denise Mariano’s work and advocacy efforts spread far and wide, however, her focus remains on advocating for and supporting families impacted by substance use disorder. She has been a strong voice for families at the national and state levels since, 2011. Mariano was selected and honored at the White House as an Advocate for Action, where she was recognized as one of the leaders across the country making a difference. She also was selected as a National Council on Alcoholism and Drug Dependence Advocacy Leader for her efforts in New Jersey. Mariano is a Peer Parent Coach at the Partnership for Drug-Free Kids and works within the Parent Support Network, where she helps develop and promote programs to support families struggling with substance use disorders and to encourage healthier behaviors and improve family cohesion. This work is based upon Community Reinforcement and Family Training, or CRAFT, and Motivational Interviewing, evidence-based models. She also serves as an Ambassador for the Partnership. Mariano is a member of her County Task Force on Opiates, a member of Faces and Voices, D.C. Program Outreach Committee and a member of New Jersey’s Experience, Hope and Strength Recovery High School Fund Raising Committee.
Empowering Families: How to Address a Loved One’s Opioid Use and Become a Family Advocate
Edward J. Markey
U.S. Senator
(D-MA)
Senator Edward J. Markey, a consumer champion and national leader on energy, environmental protection and telecommunications policy, has a prolific legislative record on major issues across the policy spectrum and a deep commitment to improving the lives of the people of Massachusetts and our country. Whether the issue is climate change, clean energy, safeguarding privacy, nuclear non-proliferation, investor protection or preserving an open Internet that spurs competition and consumer choice, Senator Markey stands up for the priorities and values of Massachusetts. Markey Headshot High Resolution
While serving for 37 years in the U.S. House of Representatives, Senator Markey fought for his constituents throughout his Congressional District. When he was Dean of the Massachusetts delegation in the House, he worked to harness the energy and influence of his colleagues on behalf of the entire Commonwealth. Elected to the Senate in a special election in June 2013, Senator Markey is bringing his experience, energy and expertise to fight for all the people of Massachusetts.
Senator Markey has amassed an unparalleled record of energy and environmental legislative achievements. He has consistently fought to create new jobs in American clean energy and served as a leading consumer champion against rising gas prices and foreign oil. He is the principal House author of the 2007 fuel economy law, which will increase fuel economy standards to 54.5 miles per gallon by 2025, the first increase in a generation. He also is the author of the appliance efficiency act of 1987, which stopped the construction of hundreds of coal-fired plants. Senator Markey authored the law that established the Northeast Home Heating Oil Reserve, ensuring that New England families won't be left out in the cold when oil prices spike. And he is the author of the revolutionary law that requires electricity regulators to open up the wholesale electric power market for the first time.
In 2009, Congressman Markey was the co-author of the landmark Waxman-Markey bill, the only comprehensive climate legislation ever to pass a chamber of Congress. It gave hope to the world that the United States was serious about addressing climate change and helped America effectively negotiate with the international community.
Senator Markey was a leading voice in the investigation into the BP oil spill. He insisted that the company reveal the true size of the spill's flow rate, raised concerns about the use of toxic chemical dispersants into the environment and forced BP to make live video footage of the oil spill available to the public on the "Spillcam" website he created. BP ultimately pled guilty to 14 counts, including one count of Obstruction of Congress for making false and misleading statements and withholding information and documents from then-Rep. Markey about the true size of the spill.
In the House of Representatives, Congressman Markey served as the Ranking Member of the Natural Resources Committee. From 2007 to 2010, he served as Chairman of the Select Committee on Energy Independence and Global Warming, a signature committee established by then-Speaker Nancy Pelosi. He also served on the Energy and Commerce Committee, where he was Chairman of the Subcommittee on Energy and the Environment.
A member of the Commerce, Science and Transportation Committee, Senator Markey is a national leader on telecommunications policy, technology and privacy. In the House, he served for 20 years as Chair or Ranking Member of the Subcommittee on Telecommunications and the Internet, where he fostered the growth of new information technologies and was the principal author of many of the laws now governing our nation's telephone, broadcasting, cable television, wireless, and broadband communications systems. He is the House author of the 1992 Cable Act, which increased choices for millions of consumers and enabled satellite-delivered programming to be more widely offered.
He also authored the law in 1993 that moved over 200 MHz of spectrum from government to commercial use, creating the 3rd, 4th, 5th, and 6th wireless phone companies. New companies entered the market with digital technology, forcing the incumbents to innovate and invest and pushing mobile phone prices down.
Congressman Markey authored the landmark Telecommunications Act of 1996, ushering competition into the telecommunications marketplace and unleashing private sector investment.
Competition remains Senator Markey's economic mantra, in his words, "ruthless Darwinian competition that would bring a smile to Adam Smith." He has been instrumental in breaking up anti-consumer, anti-innovative monopolies in electricity, long-distance and local telephone service, cable television, and international satellite services. He was one of the only members of the House Commerce Committee to fight AT&T's monopoly in the early 1980s and is a principal author of the requirement that the Bell Operating companies accept local telephone service in the 1990s. His pro-competition policies have directly benefited job creation in Massachusetts and throughout the country.
While in the House, Congressman Markey introduced the Internet Freedom Preservation Act, the first net neutrality bill introduced in Congress, to ensure that as the Internet continues to evolve, it remains a level playing field guided by the principles of openness, competition and innovation. He also has been a key leader on providing privacy protections for personal information such as medical records, financial records, and on-line purchases. He has championed strengthening privacy protections for children and is the House author of the Children's Online Privacy and Protection Act (COPPA), the primary law that safeguards children's privacy online.
From 2003 to 2009 in the House of Representatives, Senator Markey also served as a senior member of the Homeland Security Committee. In that capacity, he focused on closing gaps in our homeland defenses, particularly in the areas of nuclear, aviation, maritime, liquefied natural gas and chemical security. In the wake of the 9-11 attacks, he authored the first-ever mandate in the law that 100% of cargo on passenger planes is screened, and 100% of all maritime cargo is scanned before entering America's ports.
Senator Markey also was the leader of the national Nuclear Freeze movement and has been a Congressional champion on nuclear nonproliferation. His amendment to ban all underground nuclear testing passed in 1986, and in the 1990s, he fought to tighten controls on global trafficking in nuclear technology. Since then, Senator Markey has continued his work on nuclear nonproliferation, successfully enacting new restrictions on exports of nuclear and dual-use technologies to Iran, North Korea, and other countries designated as state sponsors of terrorism and pressing for stronger nuclear nonproliferation conditions on all future nuclear trade cooperation agreements As founder of the Nonproliferation Caucus, Senator Markey continues to spearhead efforts to prevent the spread of nuclear weapons to safeguard the future for generations to come.
He is the author of some of the most important Wall Street reform laws since the Great Depression, including statutes that strengthened penalties against insider trading, improved federal oversight over the stock and futures markets, and reformed regulation of the government securities market.
Senator Markey was born in Malden, Massachusetts, on July 11, 1946. He attended Boston College (B.A., 1968) and Boston College Law School (J.D., 1972). He served in the U.S. Army Reserve and was elected to the Massachusetts State House where he served two terms representing Malden and Melrose. He is married to Dr. Susan Blumenthal.
Plenary Session: Congressional Leaders Update
U.S. Senator
(D-MA)
Senator Edward J. Markey, a consumer champion and national leader on energy, environmental protection and telecommunications policy, has a prolific legislative record on major issues across the policy spectrum and a deep commitment to improving the lives of the people of Massachusetts and our country. Whether the issue is climate change, clean energy, safeguarding privacy, nuclear non-proliferation, investor protection or preserving an open Internet that spurs competition and consumer choice, Senator Markey stands up for the priorities and values of Massachusetts. Markey Headshot High Resolution
While serving for 37 years in the U.S. House of Representatives, Senator Markey fought for his constituents throughout his Congressional District. When he was Dean of the Massachusetts delegation in the House, he worked to harness the energy and influence of his colleagues on behalf of the entire Commonwealth. Elected to the Senate in a special election in June 2013, Senator Markey is bringing his experience, energy and expertise to fight for all the people of Massachusetts.
Senator Markey has amassed an unparalleled record of energy and environmental legislative achievements. He has consistently fought to create new jobs in American clean energy and served as a leading consumer champion against rising gas prices and foreign oil. He is the principal House author of the 2007 fuel economy law, which will increase fuel economy standards to 54.5 miles per gallon by 2025, the first increase in a generation. He also is the author of the appliance efficiency act of 1987, which stopped the construction of hundreds of coal-fired plants. Senator Markey authored the law that established the Northeast Home Heating Oil Reserve, ensuring that New England families won't be left out in the cold when oil prices spike. And he is the author of the revolutionary law that requires electricity regulators to open up the wholesale electric power market for the first time.
In 2009, Congressman Markey was the co-author of the landmark Waxman-Markey bill, the only comprehensive climate legislation ever to pass a chamber of Congress. It gave hope to the world that the United States was serious about addressing climate change and helped America effectively negotiate with the international community.
Senator Markey was a leading voice in the investigation into the BP oil spill. He insisted that the company reveal the true size of the spill's flow rate, raised concerns about the use of toxic chemical dispersants into the environment and forced BP to make live video footage of the oil spill available to the public on the "Spillcam" website he created. BP ultimately pled guilty to 14 counts, including one count of Obstruction of Congress for making false and misleading statements and withholding information and documents from then-Rep. Markey about the true size of the spill.
In the House of Representatives, Congressman Markey served as the Ranking Member of the Natural Resources Committee. From 2007 to 2010, he served as Chairman of the Select Committee on Energy Independence and Global Warming, a signature committee established by then-Speaker Nancy Pelosi. He also served on the Energy and Commerce Committee, where he was Chairman of the Subcommittee on Energy and the Environment.
A member of the Commerce, Science and Transportation Committee, Senator Markey is a national leader on telecommunications policy, technology and privacy. In the House, he served for 20 years as Chair or Ranking Member of the Subcommittee on Telecommunications and the Internet, where he fostered the growth of new information technologies and was the principal author of many of the laws now governing our nation's telephone, broadcasting, cable television, wireless, and broadband communications systems. He is the House author of the 1992 Cable Act, which increased choices for millions of consumers and enabled satellite-delivered programming to be more widely offered.
He also authored the law in 1993 that moved over 200 MHz of spectrum from government to commercial use, creating the 3rd, 4th, 5th, and 6th wireless phone companies. New companies entered the market with digital technology, forcing the incumbents to innovate and invest and pushing mobile phone prices down.
Congressman Markey authored the landmark Telecommunications Act of 1996, ushering competition into the telecommunications marketplace and unleashing private sector investment.
Competition remains Senator Markey's economic mantra, in his words, "ruthless Darwinian competition that would bring a smile to Adam Smith." He has been instrumental in breaking up anti-consumer, anti-innovative monopolies in electricity, long-distance and local telephone service, cable television, and international satellite services. He was one of the only members of the House Commerce Committee to fight AT&T's monopoly in the early 1980s and is a principal author of the requirement that the Bell Operating companies accept local telephone service in the 1990s. His pro-competition policies have directly benefited job creation in Massachusetts and throughout the country.
While in the House, Congressman Markey introduced the Internet Freedom Preservation Act, the first net neutrality bill introduced in Congress, to ensure that as the Internet continues to evolve, it remains a level playing field guided by the principles of openness, competition and innovation. He also has been a key leader on providing privacy protections for personal information such as medical records, financial records, and on-line purchases. He has championed strengthening privacy protections for children and is the House author of the Children's Online Privacy and Protection Act (COPPA), the primary law that safeguards children's privacy online.
From 2003 to 2009 in the House of Representatives, Senator Markey also served as a senior member of the Homeland Security Committee. In that capacity, he focused on closing gaps in our homeland defenses, particularly in the areas of nuclear, aviation, maritime, liquefied natural gas and chemical security. In the wake of the 9-11 attacks, he authored the first-ever mandate in the law that 100% of cargo on passenger planes is screened, and 100% of all maritime cargo is scanned before entering America's ports.
Senator Markey also was the leader of the national Nuclear Freeze movement and has been a Congressional champion on nuclear nonproliferation. His amendment to ban all underground nuclear testing passed in 1986, and in the 1990s, he fought to tighten controls on global trafficking in nuclear technology. Since then, Senator Markey has continued his work on nuclear nonproliferation, successfully enacting new restrictions on exports of nuclear and dual-use technologies to Iran, North Korea, and other countries designated as state sponsors of terrorism and pressing for stronger nuclear nonproliferation conditions on all future nuclear trade cooperation agreements As founder of the Nonproliferation Caucus, Senator Markey continues to spearhead efforts to prevent the spread of nuclear weapons to safeguard the future for generations to come.
He is the author of some of the most important Wall Street reform laws since the Great Depression, including statutes that strengthened penalties against insider trading, improved federal oversight over the stock and futures markets, and reformed regulation of the government securities market.
Senator Markey was born in Malden, Massachusetts, on July 11, 1946. He attended Boston College (B.A., 1968) and Boston College Law School (J.D., 1972). He served in the U.S. Army Reserve and was elected to the Massachusetts State House where he served two terms representing Malden and Melrose. He is married to Dr. Susan Blumenthal.
Plenary Session: Congressional Leaders Update
Joe Markiewicz
Senior Consultant
Building Stronger Communities
Joe Markiewicz is the Senior Consultant at Building Stronger Communities. Recently, he was the Program Coordinator for the Statewide Prescription Drug Overdose Reduction Initiative at the University of Kentucky. He has over 20 years' experience as a community coalition trainer, prevention planner, evaluator and youth trainer. He has been a presenter at national conferences on the subject of risk and protective factors, evidenced-based prevention strategies, youth data, community planning and positive social norming. In 2012, Markiewicz received the Erie County Award for Youth Violence Reduction and as Chair of the Erie County Collaborative Board he received the Statewide Community Coalition of the Year Award in Pennsylvania. In his previous employment, Markiewicz was a statewide planner and trainer with the Center for Juvenile Justice Training & Research, Pennsylvania Commission on Crime and Delinquency, and Juvenile Court Judge’s Commission, as well as many other youth-serving organizations. He is also a national technical assistant for the Office of Juvenile Justice Training & Research (OJJTR).
Prevention for Youth, by Youth
Senior Consultant
Building Stronger Communities
Joe Markiewicz is the Senior Consultant at Building Stronger Communities. Recently, he was the Program Coordinator for the Statewide Prescription Drug Overdose Reduction Initiative at the University of Kentucky. He has over 20 years' experience as a community coalition trainer, prevention planner, evaluator and youth trainer. He has been a presenter at national conferences on the subject of risk and protective factors, evidenced-based prevention strategies, youth data, community planning and positive social norming. In 2012, Markiewicz received the Erie County Award for Youth Violence Reduction and as Chair of the Erie County Collaborative Board he received the Statewide Community Coalition of the Year Award in Pennsylvania. In his previous employment, Markiewicz was a statewide planner and trainer with the Center for Juvenile Justice Training & Research, Pennsylvania Commission on Crime and Delinquency, and Juvenile Court Judge’s Commission, as well as many other youth-serving organizations. He is also a national technical assistant for the Office of Juvenile Justice Training & Research (OJJTR).
Prevention for Youth, by Youth
Gregory C. Marotta
President and CEO
CleanSlate
As president and CEO of CleanSlate, Marotta leads a multi-state medical group that has been a pioneer in outpatient addiction medicine and a significant partner on the front lines of the opioid epidemic. Marotta has overseen the continued rapid expansion of CleanSlate to meet the urgent demand for its medication-assisted treatment services in communities across the country. CleanSlate currently treats nearly 8,000 active patients monthly at 39 centers in eight states. In 2017, Marotta relocated CleanSlate to Nashville. His focus at CleanSlate is not only on expanding the company's own capacity to save lives but also in leading the company's public policy and information efforts to drive legislative change, increase access to care and break down the stigma around the chronic disease of addiction. Marotta brings leadership in all areas of management within startup/high-growth operations, including mergers and acquisitions, change management and strategic reorganizations. As senior vice president of national operations at U.S. Healthworks, the second-largest provider of occupational medical care, Marotta oversaw a national network of more than 230 healthcare facilities in 20 states. Prior to serving in a national capacity at U.S. Healthworks, Marotta served as senior vice president of operations in the east division and as vice president of operations at the company. Earlier in his career, Marotta served as vice president of outpatient services at the Kessler Institute for Rehabilitation, ranked by U.S. News & World Report as one of the top three rehabilitation hospitals in the country. Marotta obtained his bachelor of arts degree from Kean University and is a graduate of the Advanced Management Program at Harvard Business School.
Implementing SAMHSA TIP 63: Accessing Pharmacotherapy Across the Care Continuum - Hosted by CleanSlate
President and CEO
CleanSlate
As president and CEO of CleanSlate, Marotta leads a multi-state medical group that has been a pioneer in outpatient addiction medicine and a significant partner on the front lines of the opioid epidemic. Marotta has overseen the continued rapid expansion of CleanSlate to meet the urgent demand for its medication-assisted treatment services in communities across the country. CleanSlate currently treats nearly 8,000 active patients monthly at 39 centers in eight states. In 2017, Marotta relocated CleanSlate to Nashville. His focus at CleanSlate is not only on expanding the company's own capacity to save lives but also in leading the company's public policy and information efforts to drive legislative change, increase access to care and break down the stigma around the chronic disease of addiction. Marotta brings leadership in all areas of management within startup/high-growth operations, including mergers and acquisitions, change management and strategic reorganizations. As senior vice president of national operations at U.S. Healthworks, the second-largest provider of occupational medical care, Marotta oversaw a national network of more than 230 healthcare facilities in 20 states. Prior to serving in a national capacity at U.S. Healthworks, Marotta served as senior vice president of operations in the east division and as vice president of operations at the company. Earlier in his career, Marotta served as vice president of outpatient services at the Kessler Institute for Rehabilitation, ranked by U.S. News & World Report as one of the top three rehabilitation hospitals in the country. Marotta obtained his bachelor of arts degree from Kean University and is a graduate of the Advanced Management Program at Harvard Business School.
Implementing SAMHSA TIP 63: Accessing Pharmacotherapy Across the Care Continuum - Hosted by CleanSlate
Patrick Marshalek
MD, Associate Professor, Clinical Faculty
School of Medicine, West Virginia University
Dr. Patrick Marshalek is a psychiatrist and Associate Professor at West Virginia University (WVU) School of Medicine with specialties in behavioral medicine and psychiatry. He is board certified in psychiatry and has multiple clinical appointments at WVU and within the surrounding community, including the Chestnut Ridge Center West Virginia University, a leading regional referral center for treatment of mental health and addiction disorders. Through these appointments, Marshalek directs multiple teams, including telepsychiatry and pain resource management. His expertise includes use of telehealth and delivery of substance abuse treatment, including office-based medication assisted treatment. Marshalek has presented and published extensively on addiction medicine.
Expanding Access to OUD Treatment: The Role of Telehealth
MD, Associate Professor, Clinical Faculty
School of Medicine, West Virginia University
Dr. Patrick Marshalek is a psychiatrist and Associate Professor at West Virginia University (WVU) School of Medicine with specialties in behavioral medicine and psychiatry. He is board certified in psychiatry and has multiple clinical appointments at WVU and within the surrounding community, including the Chestnut Ridge Center West Virginia University, a leading regional referral center for treatment of mental health and addiction disorders. Through these appointments, Marshalek directs multiple teams, including telepsychiatry and pain resource management. His expertise includes use of telehealth and delivery of substance abuse treatment, including office-based medication assisted treatment. Marshalek has presented and published extensively on addiction medicine.
Expanding Access to OUD Treatment: The Role of Telehealth
Brandon Marshall
PhD, Associate Professor
Brown University
Dr. Brandon Marshall is an Associate Professor of Epidemiology at the Brown University School of Public Health. Broadly, his research focuses on HIV/AIDS, substance use epidemiology, and the social, environmental, and structural determinants of health of urban populations. He is the inaugural recipient of the National Institute on Drug Abuse "Avenir" award, which supports a research program using agent-based modeling to investigate HIV transmssion dynamics among people who use drugs and involved in a number of other NIH and CIHR-funded cohort studies of people who use drugs, street-involved youth and men who have sex with men. Marshall is also the Associate Public Health & Epidemiology Editor of the International Journal of Drug Policy.
Drug Checking: A Novel Evidence-Based Strategy for Preventing Overdose
PhD, Associate Professor
Brown University
Dr. Brandon Marshall is an Associate Professor of Epidemiology at the Brown University School of Public Health. Broadly, his research focuses on HIV/AIDS, substance use epidemiology, and the social, environmental, and structural determinants of health of urban populations. He is the inaugural recipient of the National Institute on Drug Abuse "Avenir" award, which supports a research program using agent-based modeling to investigate HIV transmssion dynamics among people who use drugs and involved in a number of other NIH and CIHR-funded cohort studies of people who use drugs, street-involved youth and men who have sex with men. Marshall is also the Associate Public Health & Epidemiology Editor of the International Journal of Drug Policy.
Drug Checking: A Novel Evidence-Based Strategy for Preventing Overdose
Lynda Martin
RN, BSN, MPA, Senior Director Clinical Operations, Government Services
Premier, Inc.
Lynda Martin is a registered nurse with more than 25 years of senior leadership and management experience in the healthcare quality, patient safety, performance improvement, infection prevention, pay-for-performance, federal contracting, regulatory and accreditation arenas. She has experience with developing innovative quality, patient safety and performance improvement programs to drive advances across the care continuum, as well as directing large-scale initiatives and engaging cross-functional teams to achieve safe, quality, cost-effective outcomes. She is skilled at establishing strategic relationships. At Premier, Martin is the director of clinical operations and the director of Premier’s Hospital Improvement Innovation Network (HIIN), a prime contractor HIIN for the Centers for Medicaid and Medicare Services Partnership for Patients program. She has responsibilities for leadership, development and execution of the clinical assessment and quality improvement strategy for the Premier HIIN program. This includes oversight of the clinical and technical assistance provided to hospitals for improving clinical processes, culture, patient safety and infection prevention and for the engaging of senior leaders, patients and families to reduce preventable harm and readmissions and improve the patient experience across the care continuum.
Hospitals in Action: Creating Safer Post-Operative Management to Reduce Opioid-Related Harm
RN, BSN, MPA, Senior Director Clinical Operations, Government Services
Premier, Inc.
Lynda Martin is a registered nurse with more than 25 years of senior leadership and management experience in the healthcare quality, patient safety, performance improvement, infection prevention, pay-for-performance, federal contracting, regulatory and accreditation arenas. She has experience with developing innovative quality, patient safety and performance improvement programs to drive advances across the care continuum, as well as directing large-scale initiatives and engaging cross-functional teams to achieve safe, quality, cost-effective outcomes. She is skilled at establishing strategic relationships. At Premier, Martin is the director of clinical operations and the director of Premier’s Hospital Improvement Innovation Network (HIIN), a prime contractor HIIN for the Centers for Medicaid and Medicare Services Partnership for Patients program. She has responsibilities for leadership, development and execution of the clinical assessment and quality improvement strategy for the Premier HIIN program. This includes oversight of the clinical and technical assistance provided to hospitals for improving clinical processes, culture, patient safety and infection prevention and for the engaging of senior leaders, patients and families to reduce preventable harm and readmissions and improve the patient experience across the care continuum.
Hospitals in Action: Creating Safer Post-Operative Management to Reduce Opioid-Related Harm
David Martin
PhD, Science Team Director
JMJ Technologies
Dr. David Martin is a pioneer in the drug testing industry. Over the past 40 years, he has built several drug testing laboratories, including one of the first laboratories specifically to monitor impaired professionals and certified to test federal employees. He is the former Chairman of the Drug and Alcohol Testing Industry Association, Drug Testing Administrator for the International Tennis Federation, member of the IOC Medical Commission, professor at University of Florida Department of Psychiatry, Lead Scientist on the U.S. State Department Afghanistan National Drug Survey, and is currently the Science Team Director of the Colombo Plan's Global Study on Toxic Adulterants in Street Drugs.
America's Hidden Drug Epidemic: It's More than Opioids
PhD, Science Team Director
JMJ Technologies
Dr. David Martin is a pioneer in the drug testing industry. Over the past 40 years, he has built several drug testing laboratories, including one of the first laboratories specifically to monitor impaired professionals and certified to test federal employees. He is the former Chairman of the Drug and Alcohol Testing Industry Association, Drug Testing Administrator for the International Tennis Federation, member of the IOC Medical Commission, professor at University of Florida Department of Psychiatry, Lead Scientist on the U.S. State Department Afghanistan National Drug Survey, and is currently the Science Team Director of the Colombo Plan's Global Study on Toxic Adulterants in Street Drugs.
America's Hidden Drug Epidemic: It's More than Opioids
J. Kevin Massey
Health Administrator
Tulane University Psychiatry Department
J. Kevin Massey is the Health Administrator for Correct Care Solutions, which is a leading, national provider of correctional health services in the United States. He leads an integrated clinical team of more than 100 professionals who deliver inpatient dental, medical, mental health and nursing; serving over 1,300 patients located at the New Orleans Jail and Hunt Mental Health Facility. Previously, Massey was the Director of Strategic Business Development and Clinical Innovation for the Weitzman Institute at the Community Health Center, Inc., which provides outpatient primary care serving over 150,000 underserved patients and tests promising innovations in primary care delivery. He has served as the Director of Injury Prevention for the State of Delaware, Department of Health, responsible for engaging state and national leaders, to improve health policy, clinical practice and executing broad-based prevention/population health programs. Prior leadership roles include: Chief Operating Officer at the Kent Community Health Center, a $20M outpatient primary care health center, and Interim Director of Marketing/Community Engagement for United Healthcare, Delaware Medicaid Managed Care Plan. Massey has served on the National Rx Drug Abuse & Heroin Summit Advisory Board since 2013, and he has co-published and presents at Rx and heroin abuse conferences nationwide.
Health Administrator
Tulane University Psychiatry Department
J. Kevin Massey is the Health Administrator for Correct Care Solutions, which is a leading, national provider of correctional health services in the United States. He leads an integrated clinical team of more than 100 professionals who deliver inpatient dental, medical, mental health and nursing; serving over 1,300 patients located at the New Orleans Jail and Hunt Mental Health Facility. Previously, Massey was the Director of Strategic Business Development and Clinical Innovation for the Weitzman Institute at the Community Health Center, Inc., which provides outpatient primary care serving over 150,000 underserved patients and tests promising innovations in primary care delivery. He has served as the Director of Injury Prevention for the State of Delaware, Department of Health, responsible for engaging state and national leaders, to improve health policy, clinical practice and executing broad-based prevention/population health programs. Prior leadership roles include: Chief Operating Officer at the Kent Community Health Center, a $20M outpatient primary care health center, and Interim Director of Marketing/Community Engagement for United Healthcare, Delaware Medicaid Managed Care Plan. Massey has served on the National Rx Drug Abuse & Heroin Summit Advisory Board since 2013, and he has co-published and presents at Rx and heroin abuse conferences nationwide.
Christine Mattson
PhD, MS, Health Scientist
Centers for Disease Control and Prevention
Dr. Christine Mattson works at the Centers for Disease Control and Prevention (CDC) on the Overdose Epidemiology and Surveillance Team as a Health Scientist. Dr. Mattson has a doctorate in epidemiology and joined CDC in 2007 as an Epidemic Intelligence Service Officer working in the Global AIDS Program. She has worked in the field of HIV prevention and surveillance domestically and internationally for over 15 years. She has a strong interest in epidemiology methods and surveillance and most of her previous publications focused on behavioral and clinical outcomes of people living with HIV. Since joining the Overdose Epidemiology and Surveillance Team, she has co-authored the first annual "Surveillance Report of Drug-Related Risks and Outcomes — United States, 2017," and she serves as a science officer on the Enhanced State Opioid Surveillance program.
Opioid and Fentanyl Overdoses: Rapid Surveillance and Regional Patterns
PhD, MS, Health Scientist
Centers for Disease Control and Prevention
Dr. Christine Mattson works at the Centers for Disease Control and Prevention (CDC) on the Overdose Epidemiology and Surveillance Team as a Health Scientist. Dr. Mattson has a doctorate in epidemiology and joined CDC in 2007 as an Epidemic Intelligence Service Officer working in the Global AIDS Program. She has worked in the field of HIV prevention and surveillance domestically and internationally for over 15 years. She has a strong interest in epidemiology methods and surveillance and most of her previous publications focused on behavioral and clinical outcomes of people living with HIV. Since joining the Overdose Epidemiology and Surveillance Team, she has co-authored the first annual "Surveillance Report of Drug-Related Risks and Outcomes — United States, 2017," and she serves as a science officer on the Enhanced State Opioid Surveillance program.
Opioid and Fentanyl Overdoses: Rapid Surveillance and Regional Patterns
Diana Maurer
Director, Homeland Security and Justice
U.S. Government Accountability Office
Diana Maurer has been a Director in the U.S. Government Accountability Office’s (GAO) Homeland Security and Justice team since 2009, where she currently leads GAO’s work reviewing justice and law enforcement issues. Her recent work includes reports and testimonies on the federal prison system, the Secret Service, combating violent extremism, the FBI’s use of facial recognition technology and audio-video policies at the Supreme Court. She has testified more than two dozen times before Congressional committees on several issues, including national drug control policy, FBI whistleblower protection, U.S. Department of Justice oversight and nuclear smuggling. From 2008-9, Maurer worked as an Acting Director in GAO’s Natural Resource and Environment team, where she managed work assessing U.S. global nuclear detection programs and enforcement of federal environmental law. From 1993-2007, she managed and led work in GAO’s International Affairs and Trade team, where she reviewed U.S. efforts to combat international terrorism and proliferation of weapons of mass destruction, U.S. assistance to the former Soviet Union, peacekeeping in the Balkans, and several other international issues. Maurer began her GAO career in 1990 in GAO’s Detroit Regional Office, where she worked on military and environmental issues.
Federal Efforts to Combat Synthetic Opioids
Director, Homeland Security and Justice
U.S. Government Accountability Office
Diana Maurer has been a Director in the U.S. Government Accountability Office’s (GAO) Homeland Security and Justice team since 2009, where she currently leads GAO’s work reviewing justice and law enforcement issues. Her recent work includes reports and testimonies on the federal prison system, the Secret Service, combating violent extremism, the FBI’s use of facial recognition technology and audio-video policies at the Supreme Court. She has testified more than two dozen times before Congressional committees on several issues, including national drug control policy, FBI whistleblower protection, U.S. Department of Justice oversight and nuclear smuggling. From 2008-9, Maurer worked as an Acting Director in GAO’s Natural Resource and Environment team, where she managed work assessing U.S. global nuclear detection programs and enforcement of federal environmental law. From 1993-2007, she managed and led work in GAO’s International Affairs and Trade team, where she reviewed U.S. efforts to combat international terrorism and proliferation of weapons of mass destruction, U.S. assistance to the former Soviet Union, peacekeeping in the Balkans, and several other international issues. Maurer began her GAO career in 1990 in GAO’s Detroit Regional Office, where she worked on military and environmental issues.
Federal Efforts to Combat Synthetic Opioids
